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Abstract
Background: This study sought to identify multimorbidity patterns and determine the association between these
latent classes with several outcomes, including health, functioning, disability, quality of life and use of services, at
baseline and after 3 years of follow-up.
Methods: We analyzed data from a representative Spanish cohort of 3541 non-institutionalized people aged 50 years
old and over. Measures were taken at baseline and after 3 years of follow-up. Latent Class Analysis (LCA) was
conducted using eleven common chronic conditions. Generalized linear models were conducted to determine
the adjusted association of multimorbidity latent classes with several outcomes.
Results: 63.8% of participants were assigned to the “healthy” class, with minimum disease, 30% were classified
under the “metabolic/stroke” class and 6% were assigned to the “cardiorespiratory/mental/arthritis” class. Significant
cross-sectional associations were found between membership of both multimorbidity classes and poorer memory,
quality of life, greater burden and more use of services. After 3 years of follow-up, the “metabolic/stroke” class was a
significant predictor of lower levels of verbal fluency while the two multimorbidity classes predicted poor quality of life,
problems in independent living, higher risk of hospitalization and greater use of health services.
Conclusions: Common chronic conditions in older people cluster together in broad categories. These broad clusters
are qualitatively distinct and are important predictors of several health and functioning outcomes. Future studies are
needed to understand underlying mechanisms and common risk factors for patterns of multimorbidity and to propose
more effective treatments.
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Background
Chronic conditions and non-communicable diseases are
the leading cause of morbidity and disability worldwide
[1]. The co-occurrence of two or more conditions, or
multimorbidity, is especially common in elderly people.
Approximately two out of three persons at retirement
age suffer from at least two chronic diseases [2]. The
therapeutic management of multimorbidity is often
complex because people suffering from multimorbidity
present high treatment burden, poorer health outcomes,
problems in independent living [3, 4] and higher rates of
mortality [5].
The classical single-disease paradigm might not be
adequate for patients with multiple chronic conditions
[6]. Studies have focused on different approaches to as-
sess multimorbidity. Counting the number of diseases
has been a commonly used method [7, 8] but results
could be affected by the number of chronic conditions
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considered. One variant is the conditional count [9, 10].
For example, people with arthritis have, on average, 3.8
co-morbid conditions, compared with 1.8 conditions
among persons without arthritis [9]. Other approaches
include the most prevalent pair combinations. Diabetes
and cataract, or asthma and chronic obstructive pul-
monary disease (COPD), are especially prevalent and as-
sociated with poor levels of quality of life and high
disability [4]. However, these approaches might not
adequately capture larger clusters of conditions linked to
greater burden. In recent years, the co-occurrence of
chronic conditions has been addressed with cluster ana-
lysis methods as they can help to identify broad comor-
bidity patterns.
Islam et al. [6] compared distinct methods to assess
multimorbidity patterns in a community sample of el-
derly people, including the most frequent pairs and trip-
lets of comorbid diseases, cluster analysis, principal
component analysis and latent class analysis (LCA).
They found considerable consistency across the analytic
methods although some differences arose, mainly due to
the underlying methodology. Cluster analysis is based on
distance measures, whereas principal components and
LCA are based on correlations, with similarities between
the last two approaches [6].
Few studies have analyzed multimorbidity patterns
using LCA. LCA is based on structural equation mode-
ling which allows identification of latent groups based
on a set of observed variables. It can be useful in
describing how people are clustered according to pat-
terns of chronic conditions and identifying the main
differences between these groups in terms of socio-
demographics, functioning and clinical characteristics.
Whitson et al. [11] reported six latent groups in a com-
munity dwelling sample of people aged 65+. These mul-
timorbidity groups were significantly associated with
emergency department use and hospitalization over 1
year. However, the authors reported also high misclas-
sification errors as one limitation of the study. There is
still a need to understand how chronic conditions are
clustered together, whether these multimorbidity pat-
terns are reliable and valid, and determine the impact on
health and functioning outcomes at baseline and lo-
ngitudinally. Moreover, there is also a need for general-
population studies to ensure the external validity of
multimorbidity patterns [12].
The aim of this study was to investigate whether
eleven common chronic conditions cluster together in a
Spanish representative sample of people aged 50 and
older according to their pattern of co-occurrence. LCA
was conducted to identify latent groups of people based
on a set of observed variables [13]. These latent groups
were then described in terms of sociodemographic
characteristics, co-morbid conditions, quality of life,
disability, functioning and cognitive function. The sec-
ond part of the analysis involved the study of the effect
of these latent co-morbid groups on several outcomes
measured at baseline and at three-year follow-up.
Methods
Design and setting
The present study used data from “Edad con Salud”, a
longitudinal, nationally representative survey of adult,
non-institutionalized people in Spain. The first wave was
part of the Collaborative Research on Ageing in Europe
(COURAGE in Europe) study [14]. A stratified, multi-
stage clustered design was used and people over 50 and
80 years old were oversampled. Strata included all
Autonomous Communities in Spain (except Ceuta and
Melilla). Data on households were provided by the
Spanish Statistical Office. A total of 4753 persons partic-
ipated in face-to-face structured interviews conducted at
their homes between 2011 and 2012. The final response
rate at baseline was 69.9%. The second wave took place
after approximately 3 years (2014–2015). 2528 partici-
pants (53.2%) completed the interview at follow-up, 259
(5.5%) had died, 862 (18.1%) declined to participate in
the second assessment, and 23.2% did not participate for
other reasons (e.g., unable to locate, institutionalization).
The present analysis focused on people aged 50 years
of age and older who completed a non-proxy interview
at baseline (n = 3625). Of these, 1970 participated in
an interview in the second wave. In a small proportion
(n = 84), a proxy responded to the second assessment
because the original participant presented some evi-
dence of cognitive deterioration. Since proxy interviews
were much shorter, we excluded these proxy interviews at
follow-up, resulting in a final n of 3541 participants at
baseline, of whom 1886 also participated in the second
assessment.
Measures
Presence or absence of eleven chronic conditions at
baseline was considered. Participants reported whether
they had received a medical diagnosis during the pre-
vious 12-months of depression, arthritis, asthma, COPD,
angina, stroke, hypertension, diabetes, edentulism and
cataract. Other symptom questions were added to the
interview based on the WHO-SAGE protocol [15] and
the adapted version of the World Health Organization
Composite International Diagnostic Interview (CIDI) for
depression [16]. These additional questions allowed us
detect undiagnosed cases. Algorithms were implemented
[17, 18] and an individual was considered to have one of
these conditions if he/she met criteria for at least the
self-reported diagnosis, or the diagnosis made according
to symptoms. The presence of hypertension was based
on self-reported diagnosis or presence of systolic
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blood pressure ≥ 140 mmHg or diastolic blood pres-
sure ≥ 90 mmHg [19, 20] measured at the time of the
interview. Blood pressure was measured twice with less
than a 1 minute interval using an arm blood pressure
monitor and taking the average of the measurements.
Interviewers recorded participants’ height and weight
using a stadiometer and a routinely calibrated electronic
weighing scale, respectively. Body Mass Index (BMI) was
calculated as weight (in kilograms) divided by the square
of height (in meters). A BMI of 30 or higher was used as
cut-off point for obesity [21].
Self-reported demographic variables at baseline in-
cluded age, gender, years of schooling, quintiles of
household income (with the first quintile indicating low-
est level and the fifth the highest), and marital status
(never married, married or currently cohabiting, sepa-
rated or divorced, and widowed).
Respondents were asked to recall a list of words three
times immediately and once after a short delay which
was filled with other cognitive tests (Consortium to
Establish a Registry for Alzheimer’s Disease) [22]. The
psychometric properties of the Word List Learning task
have previously been established [23, 24]. A composite
score was calculated as the sum of the number of cor-
rect words, ranging from 0 to 40, with higher scores
indicating better memory. Participants were asked to
name as many animals as possible in 1 minute, both at
baseline and follow-up. Animal naming tasks are consi-
dered a measure of verbal fluency whereas word-list re-
call is regarded as a measure of verbal memory.
Disability was assessed with the 12-item version of the
World Health Organization Disability Assessment
Schedule 2.0 (WHODAS 2.0) [25] which evaluates func-
tioning in six life domains. A total score was obtained as
the sum of the items and transformed into a 0 to 100
scale (higher scores indicating greater disability). Pres-
ence or absence of difficulties in independent living was
evaluated through activities of daily living (ADLs) and
instrumental activities of daily living (IADLs). ADLs
describe a set of daily self-care activities and assess the
need for help with personal care activities such as eating,
bathing and dressing; IADLs describe higher-level func-
tioning considered necessary to live independently
(using transportation, housekeeping, or preparing food).
ADLs and IADLs difficulties were present if the person
answered severe or extreme/cannot do it to any of the
questions. Quality of life was measured at baseline and
follow-up with the WHOQOL-AGE [26], a modified
version of the World Health Organization Quality of Life
instrument (WHOQOL) adapted for the elderly popu-
lation. It has 13 items and a global score can be ob-
tained, ranging from 0 (minimum quality of life) to 100
(maximum quality of life). The total number of visits to
any health professional in the last year as well as
whether the participant had been hospitalized in the pre-
vious 12 months (yes/no) was also recorded at baseline
and at follow-up.
Statistical analysis
Latent Class Analysis (LCA) was conducted on the
3541 participants at baseline using the Stata plugin [27].
Eleven chronic health conditions (arthritis, asthma,
COPD, angina, stroke, hypertension, diabetes, edentulism,
cataract, depression, and obesity) were used as observed
indicators. The optimal number of latent classes was
determined using the adjusted Bayesian Information Cri-
terion (BIC) [28] and the consistent Akaike Information
Criterion (CAIC) [29], which have been shown to be more
robust indicators of class enumeration with categorical
outcomes [30]. The adjusted BIC and CAIC were used to
compare several plausible models where the lowest values
indicate the best fitting model.
Furthermore, interpretability and clinical judgment
were used. After selecting the best model, each partici-
pant was assigned to one class according to his or her
highest computed probability of membership. Average
posterior probabilities above 70% indicate optimal fit
[31]. Each latent class was labeled according to those
chronic conditions whose prevalence exceeded the
prevalence in the full cohort [11]. The final latent groups
were compared in terms of co-morbidities and function-
ing and sociodemographic variables at baseline using
chi-squared and Kruskal-Wallis tests for significance.
Missing data at baseline and follow-up was handled
using a Stata command for Imputation by Chained Equa-
tions (ICE) [32] assuming missing-at-random (MAR). The
imputation model included all the variables used in the
regression models plus other auxiliary variables (variables
not included in the analysis model but which are po-
tential predictors of missingness [33]) (see Additional
file 1: Table S1). Since the imputed values of the con-
tinuous variables lay outside the observed data range,
they were transformed to normality before imputing
their values and then converted back to the original
variables following multiple imputation [34]. LCA was
performed without imputing missing values in the
eleven indicators because LCA is not supported by mim
command [35] for analyzing multiply imputed datasets.
Instead, missing data in one of the indicators was tolerated
and handled with a full-information maximum likelihood
(FIML) technique, assuming MAR [27]. Additional file 1:
Table S1 shows the proportion of missingness in each of
the indicators for LCA.
Multivariable linear, logistic and Poisson regression
models were computed to assess the association of each
multimorbidity class with several outcomes at baseline
and after 3 years of follow-up. Models for outcomes at
baseline were adjusted for gender, age, years of schooling,
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household income and marital status (at baseline). Models
for outcomes at follow-up were additionally adjusted for
the same measure as the outcome at baseline. Regres-
sion models were conducted separately in one hundred
imputed datasets and results combined using Rubin’s
rules [36] in Stata SE version 13 (College Station, TX).
For sensitivity analysis, the same models described
above were conducted again in the subsample of partici-
pants with valid values in all the variables (n = 1508) and
compared with the results from the imputed datasets.
Results
Latent classes of multimorbidity pattern
Table 1 shows the adjusted BIC and CAIC values for the
two to six-class models. There was an important drop in
the adjusted BIC and CAIC values from the 2-class to
the three-class model. The three-class model yielded the
lowest CAIC value (CAIC = 1542.11) and, although the
adjusted BIC corresponded to the four-class model (ad-
justed BIC = 1382.76), further inspection showed that
one of the four classes presented a posterior probability
lower than 0.7. Given the negligible difference between
three and four-class models in terms of the adjusted BIC
and following the parsimonious principle, the three-class
model was finally chosen over the rest.
Table 2 shows the distribution of sociodemographic,
clinical and functioning characteristics in the overall
sample at baseline and by multimorbidity classes. Some
63.8% of people were classified as being in the “healthy”
class, with prevalence of all conditions below that
observed in the whole sample. The “cardiorespiratory/
mental/arthritis” class (6.2%) presented excess preva-
lence of depression (39.5%), arthritis (64.0%), asthma
(73.2%), COPD (83.2%) and angina (40.0%). The “meta-
bolic/stroke” class, which comprised 29.9% of the sam-
ple, showed excess prevalence of stroke (12.3%), obesity
(55%), diabetes (35.1%) and hypertension (89.2%). The
proportion of oral problems and cataract was high in both
the “cardiovascular/mental/arthritis” and the “metabolic/
stroke” classes.
The average posterior probabilities for all three classes
exceeded 0.7 (0.85 for the “healthy” group, 0.81 for the
“cardiorespiratory/mental/arthritis” class, and 0.75 for the
“metabolic/stroke” group). Participants in the “healthy”
class were more likely to be well-classified (79.7% of them
had 0.7 or greater posterior probability). 68.6% and 60.9%
of participants presented a posterior probability equal to
or higher than 0.7 in the “cardiorespiratory/mental/arth-
ritis” and the “metabolic/stroke” class, respectively.
People in the “metabolic/stroke” and “cardiorespi-
ratory/mental/arthritis” latent groups were significantly
older than those in the “healthy” group (Table 2). There
were more females in the “metabolic/stroke” group,
whereas the highest proportion of widows was seen in
the “cardiorespiratory/mental/arthritis” class. This last
group presented fewer years of schooling. The number
of chronic conditions was significantly higher in the
“cardiorespiratory/mental/arthritis” class. The prevalence
of limitations in ADLs and IADLs was significantly
higher in the “cardiorespiratory/mental/arthritis” class.
The lowest level of quality of life was observed in the
“cardiorespiratory/mental/arthritis” class, followed by
the “metabolic/stroke” group. Level of disability was sig-
nificantly higher in the “cardiorespiratory/mental/arth-
ritis” and “metabolic/stroke” classes, compared with the
healthy group. The lowest scores in verbal memory and
verbal fluency at baseline were also seen in the “cardio-
respiratory/mental/arthritis” class.
Association between multimorbidity classes with
outcomes at baseline and after 3 years
Table 3 displays the adjusted unstandardized coefficients
for several outcomes assessed at baseline and follow-up.
The “healthy” group was used as the reference group. At
baseline, the two multimorbidity groups were associated
with all the outcomes, except for verbal fluency. Being in
the “cardiovascular/mental/arthritis” class was signi-
ficantly related to lower levels of verbal memory, higher
levels of disability, poorer quality of life, higher number
of medical visits, higher risk of limitations in ADLs (OR
= 7.91, 95%CI = 5.41–11.73, p < 0.001), IADLs (OR =
11.42, 95%CI = 8.04–16.22, p < 0.001) and more hospital
admissions (OR = 3.77, 95%CI = 2.79–5.10, p < 0.001).
Similarly, and compared with the healthy class, parti-
cipants in the “metabolic/stroke” class were more likely
to present poorer verbal memory and quality of life,
higher levels of disability and number of medical visits
in the last 12 months, greater odds for limitations in
ADLs and IADLs, and being hospitalized more fre-
quently. Inspection of ORs shows that the risk of pre-
senting limitations in ADLs and IADLs and hospital
admission was greater for people assigned to the “car-
diovascular/mental/arthritis” group than for those
assigned to the “metabolic/stroke” class.
In terms of cognitive function, verbal memory at
follow-up was not significantly associated with multi-
morbidity groups. Only people in the “metabolic/stroke”
Table 1 Comparison between models






Note: Boldface type indicates the selected model. aBIC adjusted Bayesian
Information Criterion, CAIC Consistent Akaike Information Criterion
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class presented significantly lower levels of verbal flu-
ency at follow-up, compared with the “healthy” group
(b = −0.78, SE = 0.30; p < 0.01). Being in the “cardio-
respiratory/mental/arthritis” or the “metabolic/stroke”
groups was significantly associated with lower quality
of life scores as well as a higher number of medical
visits in the previous year. Persons classified in the
“cardiorespiratory/mental/arthritis” group were four
times more likely to have limitations in ADLs (OR =
4.05, 95%CI = 2.65–6.18) and twice as likely to present
limitations in IADLs (OR = 2.17, 95%CI = 1.32–3.55) at
follow-up. Membership of the “metabolic/stroke” class
was significantly associated with greater risk of present-
ing limitations in ADLs (OR = 2.11, 95%CI = 1.64–2.72)
and limitations in IADLs (OR = 1.63, 1.17–2.29) after
3 years. Both groups, compared with the “healthy” group,
were at greater risk of hospital admission at follow-up.
Sensitivity analysis
Regression models were run again using complete case
analysis (n = 1508). In general, the results were similar
to those obtained using multiple imputation. However,




(n = 2261, 63.8%)
“Cardiorespiratory/mental/
arthritis” class (n = 220, 6.2%)
“Metabolic/stroke” class
(n = 1060, 29.9%)
P valuea
Age, mean (SD) 65.67 (10.28) 62.80 (9.46) 70.25 (9.86) 70.83 (9.67) <0.001
Female, n (%) 1931 (54.5) 1166 (51.6) 126 (57.3) 639 (60.3) <0.001
Years schooling, mean (SD) 9.94 (6.15) 11.19 (6.09) 6.96 (5.62) 7.88 (5.61) <0.001
Widowed, n (%) 748 (21.1) 336 (14.9) 76 (34.5) 336 (31.7) <0.001
Income (quintiles), n (%) <0.001
1st (worst) 672 (21.1) 467 (23.2) 35 (17.0) 170 (17.5)
2nd 668 (20.9) 323 (16.1) 73 (35.5) 272 (27.9)
3rd 693 (21.7) 395 (19.6) 53 (25.7) 245 (25.2)
4th 735 (23.0) 501 (24.9) 33 (16.0) 201 (20.6)
5th (best) 424 (13.3) 326 (16.2) 12 (5.8) 86 (8.8)
Comorbidities, n (%)
Depression 415 (11.7) 113 (5.0) 87 (39.5) 215 (20.3) <0.001
Arthritis 1051 (30.9) 319 (14.6) 130 (64.0) 602 (59.5) <0.001
Asthma 287 (8.1) 91 (4.0) 161 (73.2) 35 (3.3) <0.001
COPD 308 (8.7) 40 (1.8) 183 (83.2) 85 (8.0) <0.001
Angina 275 (7.8) 46 (2.0) 88 (40.0) 141 (13.3) <0.001
Stroke 147 (4.1) 7 (0.3) 10 (4.5) 130 (12.3) <0.001
Diabetes 578 (16.3) 139 (6.1) 67 (30.6) 372 (35.1) <0.001
Obesity 1089 (32.7) 448 (21.0) 94 (47.7) 547 (55.0) <0.001
Edentulism 640 (18.1) 167 (7.4) 71 (32.3) 402 (37.9) <0.001
Hypertension 2164 (63.2) 1096 (50.5) 142 (65.7) 926 (89.2) <0.001
Cataract 828 (23.4) 196 (8.7) 104 (47.3) 528 (49.8) <0.001
N° comorbidities, mean (SD) 2.20 (1.68) 1.18 (0.81) 5.17 (1.61) 3.76 (0.99) <0.001
N° medical visits last 12 months, mean (SD) 4.05 (6.61) 3.04 (5.22) 7.02 (8.95) 5.55 (8.06) <0.001
Hospital admission last 12 months, n (%) 790 (22.6) 374 (16.8) 98 (44.5) 318 (30.1) <0.001
Limitations in ADLs, n (%) 343 (9.7) 79 (3.5) 68 (30.9) 196 (18.5) <0.001
Limitations IADLs, n (%) 461 (13.0) 105 (4.6) 98 (44.5) 258 (24.3) <0.001
WHODAS, mean (SD) 12.69 (18.07) 6.63 (11.78) 33.77 (24.26) 21.25 (20.74) <0.001
WHOQOL-Age, mean (SD) 71.48 (14.86) 74.84 (13.04) 59.27 (17.40) 66.85 (15.37) <0.001
ANIMAL TEST, mean (SD) 16.91 (7.62) 17.97 (7.89) 14.41 (6.74) 15.17(6.72) <0.001
MEMORY score, mean (SD) 19.24 (7.07) 20.66 (7.00) 15.95 (6.32) 16.89 (6.50) <0.001
Note: COPD Chronic Obstructive Pulmonary Disease, ADL Activities of Daily Living, IADL Instrumental Activities of Daily Living, WHODAS World Health Organization
Disability Assessment Schedule 2.0, WHOQOL-Age World Health Organization Quality of Life instrument; Animal naming test scores ranged from 0 to 57; Memory
scores ranged from 0 to 40
aBased on chi-squared tests for categorical variables and Kruskal-Wallis tests for continuous variables
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when using complete cases, the “cardiorespiratory/men-
tal/arthritis” group was not associated with lower memory
scores at baseline, and being in the “metabolic/stroke”
class was not significantly related to lower verbal fluency
scores at follow-up. Conversely, membership of the “car-
diorespiratory/mental/arthritis” group appeared to be
significantly related to disability at follow-up whereas this
association was not significant when analyzing the
imputed data (see Additional file 2: Table S2).
Discussion
This study sought to describe multimorbidity patterns
using LCA in a representative sample of Spanish
community-dwelling adults over 50 years old. The LCA
procedure identified three latent classes of multimorbi-
dity which were statistically and clinically distinct, based
on the presence or absence of eleven chronic conditions.
These clusters generated using LCA were significantly
related to several health, functioning and use of health
service outcomes at baseline and were still significant
predictors of most of them after 3 years of follow-up.
Previous studies conducting LCA to describe latent
classes of co-occurring conditions in community sam-
ples of older people have yielded mixed results as
regards the number of clusters detected. Four latent
classes were identified in a cross-sectional sample of
4574 Australian seniors using eleven chronic conditions
[6], including cancer, Parkinson’s disease, or osteopor-
osis. Another study found six clusters of multimorbidity
in a sample of 14,502 people aged 65 years old and over,
using 13 conditions, which also included neurological
diseases, cancer and osteoporosis [11]. Comparison with
these studies is difficult since the results might be influ-
enced by the number and type of diseases included in
the analysis, characteristics of the sample, or how data
on diseases were collected. In our study, information
about cancer, osteoporosis and dementia was not avail-
able. Conversely, we included other highly prevalent
conditions such as edentulism, cataract and obesity.
The majority of our sample (63.8%) was classified
into the “healthy” class. This latent group has previ-
ously been reported in other studies which also conducted
LCA [6, 11]. However, the proportion classified as
“healthy” in our study is larger than that described in these
studies. This difference could be explained by the age of
participants. For example, Whitson et al. [11] found that
32.8% of their community sample was classified in the
minimal disease category but the average age was older
than in our study (76.4 vs. 65.7 years). Our findings sup-
port the existence of broad multimorbidity patterns.
These clusters are very similar to those reported in a
review where 14 studies on patterns of multimorbidity
were considered [12]. Despite the fact that there was con-
siderable heterogeneity between studies in terms of num-
ber and types of chronic conditions included or the
statistical approach used, the authors concluded that there
are at least three broad patterns; one comprising cardio-
vascular and metabolic diseases, a second one related to
mental health problems and a third including musculo-
skeletal disorders. In our study, 30% of participants were
classified under the “metabolic/stroke” category. This
cluster is close to the “metabolic syndrome” which has
Table 3 Association between latent multimorbidity membership and outcomes at baseline and follow-up
Outcomes Associations at baselinea Associations at follow-upb
Cardiorespiratory/mental/
arthritis (n = 220) (b, SE)
Metabolic/stroke
(n = 1060) (b, SE)
Cardiorespiratory/mental/
arthritis (n = 220) (b, SE)
Metabolic/strokec
(n = 1060) (b, SE)
Verbal fluency −0.78 (0.50) −0.17 (0.28) −0.78 (0.55) −0.78 (0.30)**
Verbal memory −1.39 (0.44)** −0.76 (0.25)** −0.87 (0.53) −0.12 (0.29)
Disability (WHODAS) 22.31 (1.10)*** 10.08 (0.61)*** 4.29 (1.38) 0.18 (0.75)
Quality of life −13.59 (0.99)*** −6.85 (0.55)*** −5.49 (1.21)*** −1.75 (0.66)**









Limitations in ADLs (yes/no) 7.97 (5.41–11.73)*** 4.13 (3.07–5.54)*** 4.05 (2.65–6.18)*** 2.11 (1.64–2.72)***
Limitations in IADLs (yes/no) 11.42 (8.04–16.22)*** 4.47 (3.45–5.80)*** 2.17 (1.32–3.55)** 1.63 (1.17–2.29)**
Hospital admission last 12 months (yes/no) 3.77 (2.79–5.10)*** 1.97 (1.63–2.38)*** 1.88 (1.16–3.04)* 1.53 (1.10–2.12)*
*p < 0.05, **p < 0.01, ***p < 0.001
Note: The reference group for the multimorbidity group variable was the “healthy” class
Unstandardized coefficients from linear regression models for continuous outcomes (verbal fluency, memory, disability, quality of life), and from Poisson regression models
for count data (n° medical visits)
Odds Ratios (95% confidence interval) from logistic regression models for binary outcomes (limitations in ADLs, IADLs and hospital admissions)
Models were run in 100 imputed datasets and results combined using Rubin’s rules
ADLs Activities of Daily Living, IADLs Instrumental Activities of Daily Living
aAdjusted for gender, age (at baseline), years of education (at baseline), marital status (at baseline) and income (at baseline);
bAdjusted for the same outcome measured at baseline, gender, age (at baseline), years of education (at baseline), marital status (at baseline) and income (at baseline)
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been shown to increase the risk of stroke and diabetes
[37]. The least frequent latent group was the “cardiorespi-
ratory/mental/arthritis” class. However, it appeared to be
the most severe category, with worst functioning and
greatest burden. This category clusters a large number of
pathologies together (i.e., angina, COPD, asthma, depres-
sion and arthritis). Previous studies also reported a cluster
of angina and respiratory diseases [17]. The co-occurrence
of health problems and musculoskeletal disorders has
been consistently reported [38, 39] and has been associ-
ated with a constellation of comorbidities. However, the
link between mental health conditions and COPD is still
unclear [40].
Cataract and edentulism were both highly prevalent in
the two multimorbidity clusters. In a similar study, visual
impairment was associated with a history of stroke, dia-
betes and arthritis [4, 41]. Patients with arthritis are
more likely to suffer from cataract, after adjusting for
glucocorticoid intake [42]. Heart diseases have also been
related to higher risk for cataract [43], supporting the
theory of inflammatory pathways [44]. The presence of
edentulism has been related to diabetes, coronary artery
disease, hypertension, and rheumatoid arthritis [45].
Several underlying mechanisms could explain the non-
random association between chronic conditions. Insulin
resistance has been proposed as one possible underlying
mechanism explaining the strong association between
metabolic syndrome and stroke, affecting metabolic pro-
cesses and leading to abnormalities of vascular reactivity
[37]. A change of lifestyles to reduce metabolic syn-
drome can help prevent stroke and other vascular dis-
eases. Other therapeutic strategies can include targeting
insulin resistance [37]. The association between respira-
tory diseases and coronary heart disease has previously
been established [46] and could be explained by inflam-
mation, hypoxia, or stress processes. Other environmen-
tal risk factors could include smoking or air pollution
[17]. Unexpected associations between conditions (such
as arthritis and respiratory diseases) should be studied in
the future. It has been suggested that medication could
be a risk factor for co-occurrence of certain groups of
diseases [12]. Future research should focus on finding
the underlying pathogenesis connecting these medical
conditions, and the shared risk factors.
Our findings show that these three multimorbidity
patterns are qualitatively distinct with important differ-
ences with respect to sociodemographic, clinical and
functioning aspects. Being older, female and having a
low educational level have been consistently associated
with more risk of suffering from multimorbidity [47, 48].
In common with other studies [4], our results show that
multimorbidity clusters were cross-sectionally associated
with a greater degree of disability, poor functioning,
lower quality-of-life levels, poor memory function and
greater risk of health care visits and hospitalizations.
Persons assigned to one of these two multimorbidity
clusters still presented poor quality of life, were more
likely to present problems in independent living, and
used health services more frequently (including being
hospitalized) after 3 years of follow-up.
One interesting result is the significant association be-
tween multimorbidity class membership and cognitive
function. Worse verbal fluency at follow-up was only
linked to membership of the “metabolic/stroke” class.
Depression, which is part of the “cardiovascular/mental/
arthritis” cluster, has been consistently linked to memory
complaints [49] as well as worse performance in mem-
ory tests [50]. Previous longitudinal studies have also re-
ported an association between musculoskeletal diseases,
lung diseases or arthritis, with cognitive decline [51].
Vascular risk factors and vascular diseases, such as
stroke, have been consistently associated with cognitive
deterioration in older adults [52]. Similarly, Ganguli et
al. [53] found cross-sectional associations between a his-
tory of stroke, diabetes and abdominal adiposity with
worse memory and executive function in a population-
based cohort of old people, although these associations
were not observed after 4 years of follow-up. The au-
thors suggested that the effect of these diseases on brain
structures would be static rather than progressive [53].
Performance in memory tests might also be affected by
the learning effect [54]. Longer follow-up periods are
needed to observe possible cognitive decline over time
associated with these multimorbidity clusters and to
avoid possible learning effects.
Some limitations should be considered when interpre-
ting our findings. In our study, some diseases were not
evaluated (such as cancer or neurological diseases) and
the inclusion of additional chronic conditions might
have yielded some different patterns. The COURAGE
protocol included a limited number of chronic con-
ditions based on their high prevalence and impact on
health outcomes. Conversely, depression and obesity
were considered in our study, although they are com-
monly omitted in other research. Second, the presence
of chronic diseases was partially based on self-reporting,
and can thus be affected by measurement errors or lack
of accuracy. However, the literature shows that self-
reported measures of chronic diseases are widely used in
large population-based studies and show reasonable ac-
curacy [55–57]. Moreover, we used additional questions
about symptoms during the interview, allowing us to de-
tect undiagnosed cases. For hypertension and obesity,
objective measures were obtained during the interview.
Next, misclassification of persons assigned to each latent
class is reasonable [31]. However, there is still some de-
gree of uncertainty associated with latent class member-
ship and results should be interpreted with caution [27].
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Finally, the use of multiple imputations could add some
bias. Nevertheless, the sensitivity analysis showed similar
results. The few differences between results with
complete cases and imputed data might be explained by
greater change variation when using the former, and be-
cause under MAR assumption, multiple imputation
should correct biases that may arise in complete cases
analyses [58].
Conclusions
This study identified three qualitatively separate, broad
multimorbidity clusters using LCA in a Spanish nation-
ally representative sample of older adults with distinct
clinical and sociodemographic characteristics. The latent
classes identified presented relatively low misclassifica-
tion errors, and demonstrated predictive and external
validity. Multimorbidity has been consistently related to
greater burden and increased use of health services. The
single-disease paradigm does not seem to fit the majority
of persons with more than one chronic condition. Future
efforts should focus on the underlying mechanisms of
these multimorbidity clusters (lifestyles, metabolic or in-
flammatory factors, stress, and environmental factors)
and determine targets for prevention and intervention.
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